Aerosol Delivery of Curcumin Reduced Amyloid-β Deposition and Improved Cognitive Performance in a Transgenic Model of Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 55, Issue 2, 2017, Pages 797-811

  McClure, Richard ^a,b,e   Ong, Henry ^a,b   Janve, Vaibhab ^a,b   Barton, Shawn ^a,b   Zhu, Meiying ^a,b   Li, Bo ^a,b   Dawes, Mary ^e   Jerome, W Gray ^b   Anderson, Adam ^a,b,c   Massion, Pierre ^d   Gore, John C ^a,b,c,e   Pham, Wellington ^a,b,c,d,e  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aerosol; amyloid ; curcumin; nebulization

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; AMYLOID PRECURSOR PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN 1;

AEROSOL; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; LUNG TOXICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBICULUM; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; COGNITIVE DEFECT; COMPLICATION; DENDRITIC SPINE; DISEASE MODEL; DRUG EFFECTS; GENETICS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAZE TEST; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; SHORT TERM MEMORY; TRANSGENIC MOUSE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ADMINISTRATION, INHALATION; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COGNITION DISORDERS; CURCUMIN; DENDRITIC SPINES; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MAZE LEARNING; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; NEURONS; PRESENILIN-1;

EID: 84999106787     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160289     Document Type: Article

References (46)

1. Ramos-Rodriguez JJ, Pacheco-Herrero M, Thyssen D, Murillo-Carretero MI, Berrocoso E, Spires-Jones TL, Bacskai BJ, Garcia-Alloza M (2013) Rapid beta-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice. J Neuropathol Exp Neurol 72, 272-285.
2. Irvine GB, El-Agnaf OM, Shankar GM, Walsh DM (2008) Protein aggregation in the brain: The molecular basis for Alzheimer's and Parkinson's diseases. Mol Med 14, 451-464.
3. Selkoe DJ (2011) Alzheimer's disease. Cold Spring Harb Perspect Biol 3, 1-16.
4. Pardridge WM (2009) Alzheimer's disease drug development and the problem of the blood-brain barrier. Alzheimers Dement 5, 427-432.
5. Jones NS, Quraishi S, Mason JD (1997) The nasal delivery of systemic drugs. Int J Clin Pract 51, 308-311.
6. McMartin C, Hutchinson LE, Hyde R, Peters GE (1987) Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J Pharm Sci 76, 535-540.
7. Ghosh S, Banerjee S, Sil PC (2015) The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. Food Chem Toxicol 83, 111-124.
8. Parada E, Buendia I, Navarro E, Avendano C, Egea J, Lopez MG (2015) Microglial HO-1 induction by curcumin provides antioxidant, anti-neuroinflammatory and glioprotective effects. Mol Nutr Food Res 59, 1690-1700.
9. Sandersen C, Bienzle D, Cerri S, Franck T, Derochette S, Neven P, Mouytis-Mickalad A, Serteyn D (2015) Effect of inhaled hydrosoluble curcumin on inflammatory markers in broncho-alveolar lavage fluid of horses with LPS-induced lung neutrophilia. Multidiscip Respir Med 10, 16.
10. Santos AM, Lopes T, Oleastro M, Gato IV, Floch P, Benejat L, Chaves P, Pereira T, Seixas E, Machado J, Guerreiro AS (2015) Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model. Nutrients 7, 306-320.
11. Galaly SR, Ahmed OM, Mahmoud AM (2014) Thymoquinone and curcumin prevent gentamicin-induced liver injury by attenuating oxidative stress, inflammation and apoptosis. J Physiol Pharmacol 65, 823-832.
12. Rashid K, Sil PC (2015) Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol Appl Pharmacol 282, 297-310.
13. Das L, Vinayak M (2015) Long term effect of curcumin in restoration of tumour suppressor p53 and phase-II antioxidant enzymes via activation of Nrf2 signalling and modulation of inflammation in prevention of cancer. PLoS One 10, e0124000.
14. Das L, Vinayak M (2014) Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1 (IL-1alpha and IL-1beta) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice. Int Immunopharmacol 20, 141-147.
15. Das L, Vinayak M (2012) Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-kappaB signalling in lymphoma-bearing mice. Biosci Rep 32, 161-170.
16. Loch-Neckel G, Santos-Bubniak L, Mazzarino L, Jacques AV, Moccelin B, Santos-Silva MC, Lemos-Senna E (2015) Orally administered chitosan-coated polycaprolactone nanoparticles containing curcumin attenuate metastatic melanoma in the lungs. J Pharm Sci 104, 3524-3534.
17. Mancarella S, Greco V, Baldassarre F, Vergara D, Maffia M, Leporatti S (2015) Polymer-coated magnetic nanoparticles for curcumin delivery to cancer cells. Macromol Biosci 15, 1365-1374.
18. Parashar G, Capalash N (2016) Promoter methylationindependent reactivation of PAX1 by curcumin and resveratrol is mediated by UHRF1. Clin Exp Med 16, 471-478.
19. Ahmad MZ, Alkahtani SA, Akhter S, Ahmad FJ, Ahmad J, Akhtar MS, Mohsin N, Abdel-Wahab BA (2016) Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: Current stateof-The-art. J Drug Target 24, 273-293.
20. Endo H, Nikaido Y, Nakadate M, Ise S, Konno H (2014) Structure activity relationship study of curcumin analogues toward the amyloid-beta aggregation inhibitor. Bioorg Med Chem Lett 24, 5621-5626.
21. Maiti P, Manna J, Veleri S, Frautschy S (2014) Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin. Biomed Res Int 2014, 495091.
22. Malar DS, Devi KP (2014) Dietary polyphenols for treatment of Alzheimer's disease-future research and development. Curr Pharm Biotechnol 15, 330-342.
23. McClure R, Yanagisawa D, Stec D, Abdollahian D, Koktysh D, Xhillari D, Jaeger R, Stanwood G, Chekmenev E, Tooyama I, Gore JC, Pham W (2015) Inhalable curcumin: Offering the potential for translation to imaging and treatment of Alzheimer's disease. J Alzheimers Dis 44, 283-295.
24. Eimer WA, Vassar R (2013) Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Mol Neurodegener 8, 2.
25. McClure RA, Chumbley CW, Reyzer ML, Wilson K, Caprioli RM, Gore JC, Pham W (2013) Identification of promethazine as an amyloid-binding molecule using a fluorescence high-throughput assay and MALDI imaging mass spectrometry. Neuroimage Clin 2, 620-629.
26. Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, Guillozet-Bongaarts A, Ohno M, Disterhoft J, Van Eldik L, Berry R, Vassar R (2006) Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. J Neurosci 26, 10129-10140.
27. PhamW, Zhao BQ, Lo EH, Medarova Z, Rosen B, Moore A (2005) Crossing the blood-brain barrier:Apotential application of myristoylated polyarginine for in vivo neuroimaging. Neuroimage 28, 287-292.
28. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21, 8370-8377.
29. Tjalve H, Henriksson J, Tallkvist J, Larsson BS, Lindquist NG (1996) Uptake of manganese and cadmium from the nasal mucosa into the central nervous system via olfactory pathways in rats. Pharmacol Toxicol 79, 347-356.
30. WitterMP, AmaralDG(1991) Entorhinal cortex of the monkey: V. Projections to the dentate gyrus, hippocampus, and subicular complex. J Comp Neurol 307, 437-459.
31. Price JL (1973) An autoradiographic study of complementary laminar patterns of termination of afferent fibers to the olfactory cortex. J Comp Neurol 150, 87-108.
32. Insausti R, Marcos P, Arroyo-Jimenez MM, Blaizot X, Martinez-Marcos A (2002) Comparative aspects of the olfactory portion of the entorhinal cortex and its projection to the hippocampus in rodents, nonhuman primates, and the human brain. Brain Res Bull 57, 557-560.
33. van Groen T, Miettinen P, Kadish I (2003) The entorhinal cortex of the mouse: Organization of the projection to the hippocampal formation. Hippocampus 13, 133-149.
34. Trujillo-Estrada L, Davila JC, Sanchez-Mejias E, Sanchez-Varo R, Gomez-Arboledas A, Vizuete M, Vitorica J, Gutierrez A (2014) Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-beta accumulation in AbetaPP/PS1 Alzheimer's disease mice subiculum. J Alzheimers Dis 42, 521-541.
35. Ding SL (2013) Comparative anatomy of the prosubiculum, subiculum, presubiculum, postsubiculum, and parasubiculum in human, monkey, and roden. J Comp Neurol 521, 4145-4162.
36. Davies CA, Mann DM, Sumpter PQ, Yates PO (1987) A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease. J Neurol Sci 78, 151-164.
37. Simic G, Kostovic I,Winblad B, Bogdanovic N (1997) Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 379, 482-494.
38. Quinn J, Davis F, Woodward WR, Eckenstein F (2001) Beta-amyloid plaques induce neuritic dystrophy of nitric oxide-producing neurons in a transgenic mouse model of Alzheimer's disease. Exp Neurol 168, 203-212.
39. Brendza RP, Bacskai BJ, Cirrito JR, Simmons KA, Skoch JM, Klunk WE, Mathis CA, Bales KR, Paul SM, Hyman BT, Holtzman DM (2005) Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest 115, 428-433.
40. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
41. Kitazawa M, Oddo S,Yamasaki TR, Green KN, LaFerlaFM (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 25, 8843-8853.
42. McGeer EG, McGeer PL (1998) The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol 33, 371-378.
43. Mackenzie IR (2001) Postmortem studies of the effect of anti-inflammatory drugs on Alzheimer-type pathology and associated with inflamation. Neurobiol Aging 22, 819-822.
44. Wahlstrom B, Blennow G (1978) A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 43, 86-92.
45. Kelloff GJ, Crowell JA, Hawk ET, Steele VE, Lubet RA, Boone CW, Covey JM, Doody LA, Omenn GS, Greenwald P, HongWK,Parkinson DR, Bagheri D, BaxterGT, Blunden M, Doeltz MK, Eisenhauer KM, Johnson K, Knapp GG, Longfellow DG, Malone WF, Nayfield SG, Seifried HE, Swall LM, Sigman CC (1996) Strategy and planning for chemopreventive drug development: Clinical development plans II. J Cell Biochem Suppl 26, 54-71.
46. Gupta B,Kulshrestha VK, Srivastava RK, PrasadDN(1980) Mechanisms of curcumin induced gastric ulcer in rats. Indian J Med Res 71, 806-814.